Poulton Stuart sold KPTI
February 15, 2024 · Form 4 insider transaction
Poulton Stuart sold 5,748 shares of Karyopharm Therapeutics Inc. at $1.33 per share, a transaction worth $7.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,748
Price
$1.33
Total value
$7.6K
InsiderPoulton Stuart
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 15, 2024
Filing dateFebruary 20, 2024
Shares owned after163,871
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.